SCHEMBL9848442

SCHEMBL9848442

N#CC(CN)c1cccc(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.53
ESR2 Q92731 6/20 0.53
ADRB1 P08588 2/20 0.43
ADRA1A P35348 2/20 0.43
MIF P14174 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2B P41595 1/20 0.43
CCR1 P32246 1/20 0.42
ENPP2 Q13822 1/20 0.41
HIF1A Q16665 3/20 0.41
DRD1 P21728 2/20 0.41
ADRB2 P07550 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRB3 P13945 1/20 0.41
TSHR P16473 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
NFKB1 P19838 1/20 0.41
HTR7 P34969 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10599419 0.98 ESR1 (0.51) ESR1ESR2ADRB1ADRA1AMIF
SCHEMBL28049229 0.82 ESR1 (0.53) ESR1ESR2ADRB1ADRA1AMIF
SCHEMBL6719945 0.82 ADRB1 (0.43) ESR1ESR2ADRB1ADRA1AMIF
Hydrochloric Acid SCHEMBL10772227 0.81 LMNA (0.42) ESR1ESR2ADRB1ADRA1AMIF
SCHEMBL7008435 0.79 ESR1 (0.50) ESR1ESR2ADRB1ADRA1AMIF
SCHEMBL28494873 0.79 PNMT (0.41) TSHRGAAALDH1A1MEN1KMT2A
SCHEMBL28748834 0.79 SLC6A2 (0.41) KMT2ATAAR1
SCHEMBL11019443 0.78 ESR1 (0.56) ESR1ESR2CCR1TSHRSLC6A3
SCHEMBL10600837 0.77 ESR1 (0.63) ESR1ESR2ADRA1AHIF1ADRD1
SCHEMBL1856265 0.77 TAAR1 (0.52) HTR2ATSHRSLC6A3TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0219961-B1 IRREVERSIBLE DOPAMINE-B-HYDROXYLASE INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1989-03-08 EP claimed
US-4760089-A Benzonitrile derivative; enzyme inhibitor SMITHKLINE BECKMAN CORPORATION (US) 1988-07-26 US claimed
EP-0219961-A1 Irreversible dopamine-B-hydroxylase inhibitors SMITHKLINE BECKMAN CORPORATION (US) 1987-04-29 EP claimed
EP-0432442-A1 ACAT inhibitors WARNER-LAMBERT COMPANY (US) 1991-06-19 EP disclosed
EP-0219961-B1 IRREVERSIBLE DOPAMINE-B-HYDROXYLASE INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1989-03-08 EP disclosed
US-4760089-A Benzonitrile derivative; enzyme inhibitor SMITHKLINE BECKMAN CORPORATION (US) 1988-07-26 US disclosed
EP-0219961-A1 Irreversible dopamine-B-hydroxylase inhibitors SMITHKLINE BECKMAN CORPORATION (US) 1987-04-29 EP disclosed